At the news
? NEUTRALIMPACT 3/10 6-K filed May 12, 2026 at 17:11 ET
Dr. Reddy's Laboratories filed its Q4 FY26 audited financial results presentation via a 6-K on May 12, 2026. The filing is a routine earnings disclosure with no specific financial figures or guidance provided in the document text, making the material impact unclear.
- Filed Q4 FY26 audited financial results presentation under Regulation 30 of SEBI Listing Regulations
- Filing date: May 12, 2026
- No specific financial figures (revenue, EPS, margins) or guidance were disclosed in the filing text
- Document content consists of a cover letter and graphic images of the presentation, not extractable text
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access